The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): Study protocol for a randomized controlled trial and progress

Hyun Ah Kim, Sei Hyun Ahn, Seok Jin Nam, Seho Park, Jungsil Ro, Seock Ah Im, Yong Sik Jung, Jung Han Yoon, Min Hee Hur, Yoon Ji Choi, Soo Jung Lee, Joon Jeong, Se Heon Cho, Sung Yong Kim, Min Hyuk Lee, Lee Su Kim, Byung In Moon, Tae Hyun Kim, Chanheun Park, Sei Joong KimSung Hoo Jung, Heungkyu Park, Geum Hee Gwak, Sun Hee Kang, Jong Gin Kim, Jeryong Kim, Su Yun Choi, Cheol Wan Lim, Doyil Kim, Youngbum Yoo, Young Jin Song, Yoon Jung Kang, Sang Seol Jung, Hyuk Jai Shin, Kwan Ju Lee, Se Hwan Han, Eun Sook Lee, Wonshik Han, Hee Jung Kim, Woo Chul Noh

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): Study protocol for a randomized controlled trial and progress'. Together they form a unique fingerprint.

Medicine and Dentistry